If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched ...

Docusign is a growth stock with 11% upside, driven by AI innovation and strong cash flow. Read more on key metrics and ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...

The time for trashy stocks may be approaching, says Goldman Sachs. Investors would do well to prepare fora shift in market leadership toward companies in dire financial shape if the economy proves to ...

Baillie Gifford's Q2 2025 portfolio grew to $134B, focusing on growth stocks like NVIDIA and MercadoLibre. Click here to read ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a smart beta exchange traded fund launched on 11/01/2006.

Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.

We came across a bullish thesis on Alexandria Real Estate Equities, Inc. on Compounding Dividends’s Substack by TJ ...

The number of significant shareholder protests has more than doubled so far this year compared with a year ago, with 11 FTSE ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...